Table A2.
Outcome Scores and Improvement From Baseline in the Analyzed Studies a
| Raw Score, Mean ± SD (% of Improvement vs Baseline) | |||||||
|---|---|---|---|---|---|---|---|
| First Author | Baseline | 4 wk | 8 wk | 12 wk | 24 wk | 52 wk | 104 wk |
| VAS (0 Min–10 Max Pain) | |||||||
| Alessio-Mazzola 1 | 8.40 ± 1.10 | NR | NR | NR | NR | NR | 0.90 ± 1.60 (89.3) b |
| Bashir 2 | 7.73 ± 0.81 | NR | 0.30 ± 0.55 (96.1) b | NR | 0.30 ± 0.70 (96.1) b | NR | NR |
| Behera 3 | 7.50 ± 6.40 | 6.20 ± 0.90 (17.7) | NR | 4.30 ± 1.60 (42.5) | 2.50 ± 2.10 (67.2) b | 1.30 ± 1.40 (83.1) b | NR |
| Gautam 11 | 7.10 ± 0.80 | NR | NR | 1.80 ± 0.60 (74.6) b | 1.60 ± 0.50 (77.5) b | NR | NR |
| Gosens 14 | 6.90 ± 1.60 | 5.60 ± 2.40 (19.3) | 4.80 ± 2.50 (30.9) b | 4.00 ± 2.10 (41.7) b | 3.30 ± 3.10 (52.3) b | 2.60 ± 3.10 (62.5) b | 2.10 ± 2.80 (69.1) b |
| Gupta 16 | 8.10 ± 0.77 | 3.80 ± 1.23 (53.1) b | 3.05 ± 1.30 (62.3) b | 2.90 ± 1.40 (64.2) b | NR | NR | NR |
| Gupta 15 | 8.10 ± 0.85 | NR | NR | 0.40 ± 0.60 (95.1) b | NR | 0.25 ± 0.55 (96.9) b | NR |
| Joshi 18 | 8.30 ± NR | NR | NR | NR | NR | NR | NR |
| Karaduman 19 | 7.03 ± NR | 3.79 ± NR (46.1) b | NR (60.0) b | NR | NR (81.0) b | NR (83.0) b | NR |
| Linnanmäki 22 | 5.70 ± 1.70 | 5.00 ± 2.00 (12.3) | 4.20 ± 2.20 (26.3) b | 4.30 ± 2.60 (24.6) b | 3.9 ± 2.50 (31.6) b | 2.70 ± 2.40 (52.6) b | NR |
| Merolla 23 | 7.60 ± NR | 4.50 ± NR (40.8) b | 2.50 ± NR (67.1) b | 1.50 ± NR (80.3) b | 1.10 ± NR (85.5) b | 0.60 ± NR (92.1) b | 7.10 (6.6) |
| Mishra 24 | NR | NR (38.4) | NR (53.9) b | NR (55.1) | NR (71.5) b | NR | NR |
| Montalvan 25 | 6.80 ± 0.80 | 5.80 ± 1.90 (14.7) | NR | 3.60 ± 1.90 (47.1) | 2.50 ± 1.60 (63.2) b | 1.70 ± 1.50 (75.0) b | NR |
| Raeissadat 30 | 7.10 ± 1.20 | 4.17 ± 2.20 (41.3) b | 3.29 ± 2.10 (53.7) b | NR | 2.91 ± 2.47 (59.0) b | 3.29 ± 2.41 (53.7) b | NR |
| Saurabh 32 | 7.70 ± NR | NR | NR | 3.20 ± NR (58.4) b | 1.80 ± NR (76.6) b | NR | NR |
| Tan 36 | 7.30 ± 0.40 | 2.00 ± 0.60 (72.8) b | NR | NR | 1.10 ± 0.20 (84.5) b | 0.80 ± 0.30 (88.7) b | NR |
| Tetschke 37 | 5.23 ± 1.84 | NR | 3.67 ± 2.04 (29.8) | NR | 2.67 ± 1.59 (48.9) b | 1.81 ± 2.02 (65.4) b | NR |
| Thanasas 38 | 6.10 ± NR | NR | NR | 1.92 ± NR (68.5) | 1.78 ± NR (70.8) | NR | NR |
| Vadapalli 39 | 7.37 ± 0.90 | 3.32 ± 1.06 (55.0) b | NR | 0.78 ± 1.00 (89.4) b | 0.56 ± 0.81 (92.4) b | NR | NR |
| Yadav 40 | 7.60 ± NR | 4.60 ± NR (39.5) b | NR | 1.60 ± NR (78.9) b | NR | NR | NR |
| Yerlikaya 41 | 8.30 ± 1.75 | 5.70 ± 2.65 (31.3) b | 4.75 ± 3.05 (42.8) b | NR | NR | NR | NR |
| DASH (0 Min–100 Max Disability) | |||||||
| Alessio-Mazzola 1 | 65.1 ± 10.5 | NR | NR | NR | NR | NR | 5.5 ± 9.5 (91.6) b |
| Gautam 11 | 69.7 ± 6.1 | NR | NR | 33.6 ± 5.1 (51.8) b | 32.0 ± 4.5 (54.1) b | NR | NR |
| Glanzmann 12 | 50.3 ± NR | 42.0 ± 18.0 (16.5) | 32.1 ± 17.7 (36.2) | NR | 20.7 ± 18.5 (58.8) b | NR | NR |
| Gosens 14 | 54.3 ± 19.5 | 43.1 ± 21.6 (20.6) b | 37.2 ± 24.7 (31.5) b | 21.3 ± 22.0 (60.8) b | 27.8 ± 24.7 (48.8) b | 20.0 ± 23.5 (63.2) b | 17.6 ± 24.0 (67.6) b |
| Gupta 16 | 72.0 ± 6.5 | 36.2 ± 9.4 (49.7) b | 33.3 ± 6.6 (53.8) b | 33.6 ± 9.5 (53.3) b | NR | NR | NR |
| Gupta 15 | 87.1 ± 5.7 | NR | NR | 35.1 ± 3.1 (59.7) | NR | 31.6 ± 3.9 (63.7) | NR |
| Joshi 18 | 78.3 ± NR | NR | NR | 29.6 ± NR (62.2) b | NR | NR | NR |
| Lebiedziński 21 | 53.2 ± 15.5 | NR | NR | NR | 14.2 ± 13.4 (73.3) b | 9.9 ± 17.1 (81.4) b | NR |
| Linnanmäki 22 | 35.6 ± 15.5 | 31.0 ± 18.0 (12.9) | 24.0 ± 19.0 (32.6) | 24.0 ± 19.0 (32.6) | 25.0 ± 18.0 (29.8) | 19.0 ± 20.0 (46.6) | NR |
| Palacio 28 | 45.7 ± NR | NR | NR | 10.7 ± NR (76.6) b | NR | NR | NR |
| Tetschke 37 | 37.0 ± 18.3 | NR | 29.8 ± 21.1 (19.5) | NR | 26.5 ± 21.1 (28.4) | 18.2 ± 19.5 (50.8) | NR |
| Yadav 40 | 88.0 ± NR | 62.5 ± NR (29.0) b | NR | 34.2 ± NR (61.2) b | NR | NR | NR |
| PRTEE (0 Min–100 Max Pain and Disability) | |||||||
| Alessio-Mazzola 1 | 60.1 ± 5.6 | NR | NR | NR | NR | NR | 15.9 ± 4.1 (73.5) b |
| Creaney 5 | 45.8 ± NR | NR | NR | 33.0 ± NR (72.1) b | 35.8 ± NR (76.4) b | NR | NR |
| Glanzmann 12 | 54.0 ± NR | 42.3 ± 19.6 (21.7) | 31.8 ± 20.9 (41.1) | NR | 23.2 ± 18.2 (57.0) b | NR | NR |
| Khattab 20 | 60.4 ± 21.4 | NR | NR | NR | 40.2 ± 22.8 (33.4) b | NR | NR |
| Merolla 23 | 70.1 ± NR | 63.0 ± NR (10.1) | 29.6 ± NR (57.8) b | 17.7 ± NR (74.8) b | 12.3 ± NR (82.4) b | 9 ± NR (87.2) b | 69.2 ± NR (1.3) |
| Mishra 24 | 54.2 ± NR | 42.8 ± NR (21.0) | 32.0 ± NR (41.0) | 27.1 ± NR (50.0) | 16.2 ± NR (70.1) | NR | NR |
| Palacio 28 | 47.1 ± NR | NR | NR | 13.0 ± NR (72.4) b | NR | NR | NR |
| MAYO (0 Poor–100 Excellent) | |||||||
| Behera 3 | 63.2 ± 10.2 | 78.3 ± 10.4 (23.9) | NR | 84.7 ± 9.2 (34.0) | 88.8 ± 8.4 (40.5) b | 92.8 ± 6.0 (46.8) b | NR |
| Gautam 11 | 56.1 ± 6.9 | NR | NR | 70.2 ± 2.2 (25.1) b | 70.7 ± 3.0 (26.0) b | NR | NR |
| Gupta 15 | 49.5 ± 0.8 | NR | NR | 97.2 ± 4.7 (96.4) b | NR | 98.2 ± 4.7 (98.4) b | NR |
| Karaduman 19 | 50.3 ± NR | 71.3 ± NR (41.7) b | NR (52.0) b | NR | NR (72.0) b | NR (74.0) b | NR |
| Raeissadat 30 | 53.9 ± 16.0 | 72.1 ± 16.0 (33.8) b | 79.5 ± 12.0 (47.5) b | NR | 81.2 ± 16.0 (50.6) b | 78.2 ± 18.0 (45.1) b | NR |
| Tan 36 | 61.9 ± 3.0 | 89.6 ± 4.3 (44.7) b | NR | NR | 92.5 ± 3.3 (49.4) b | 97.6 ± 2.1 (57.7) b | NR |
a DASH, Disabilities of the Arm, Shoulder and Hand; max, maximum; MAYO, Mayo Clinic Performance Index; min, minimum; NR, not reported; PRTEE, Patient-Rated Tennis Elbow Evaluation; VAS, visual analog scale for pain.
b Statistically significant difference versus baseline, as stated in source study (P < .05).